Cypress Capital Group Pfizer Inc Transaction History
Cypress Capital Group
- $827 Million
- Q2 2024
A detailed history of Cypress Capital Group transactions in Pfizer Inc stock. As of the latest transaction made, Cypress Capital Group holds 118,118 shares of PFE stock, worth $3.5 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
118,118
Previous 133,656
11.63%
Holding current value
$3.5 Million
Previous $3.71 Million
10.9%
% of portfolio
0.4%
Previous 0.45%
Shares
29 transactions
Others Institutions Holding PFE
# of Institutions
3,218Shares Held
3.71BCall Options Held
73.2MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$15.2 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$12.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$8.51 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.93 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA117MShares$3.48 Billion0.63% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $166B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...